Showing results (571-580 of 1,129) with videos related to
Sort By:
Pageof 113
Best Practice & Research. Clinical Haematology|March 25, 2021
Mechanisms for resistance in AML insights into molecular pathways mediating resistance to venetoclaxMarina Y KonoplevaBest Practice & Research. Clinical Haematology|March 25, 2021
What are the molecular mechanisms driving the switch from MPNs to leukemia?Xiaoli Wang, Ronald HoffmanBest Practice & Research. Clinical Haematology|March 25, 2021
CAR T in adult ALL: When and for whom?Matthew P Connor, Noelle V FreyBest Practice & Research. Clinical Haematology|September 6, 2014
Hereditary erythrocytosis, thrombocytosis and neutrophiliaWan-Jen Hong, Jason GotlibBest Practice & Research. Clinical Haematology|September 6, 2014
Leukemic transformation in myeloproliferative neoplasms: therapy-related or unrelated?Magnus Björkholm, Malin Hultcrantz, Åsa Rangert DerolfBest Practice & Research. Clinical Haematology|September 6, 2014
Prognostication in MF: from CBC to cytogenetics to molecular markersAmy Zhou, Stephen T OhBest Practice & Research. Clinical Haematology|September 6, 2014
Rationale for combination therapy in myelofibrosisJohn MascarenhasBest Practice & Research. Clinical Haematology|October 21, 2017
The biology of Philadelphia chromosome-like ALLKathryn G RobertsBest Practice & Research. Clinical Haematology|October 21, 2017
How is the Ph-like signature being incorporated into ALL therapy?Luke Maese, Sarah K Tasian, Elizabeth A RaetzBest Practice & Research. Clinical Haematology|October 21, 2017
Which patients should I transplant with acute lymphoblastic leukemia?Tsofia Inbar, Jacob M Rowe, Netanel A HorowitzPageof 113